FAH Applauds Senate Passage of Drug Quality and Security Act

Yesterday, the Senate passed important legislation regarding additional measures to ensure the safety and quality of compounded pharmaceutical products, better known as the Drug Quality and Security Act. “The Senate is to be commended for passing the Drug Quality and Security Act,” said FAH President and CEO Chip Kahn.  “This much-needed legislation will help ensure that consumers have peace of mind about the safety and quality of compounded prescription drugs. It also is important that the measure assures the ability of hospitals to provide patients with the safe, reliable and effective pharmaceutical products required for their care.” As outlined in […] Read More »

Providing Patients Safe and Effective Pharmaceutical Products

As Congress continues consideration of legislation to address the complex and difficult issues around needed oversight of pharmaceutical compounding, America’s hospitals know that protecting patients is always job number one. Community hospitals across the nation rely on compounded pharmaceutical products for a variety of reasons, such as to address the recent severe drug shortage and occasional lack of availability of critical pharmaceuticals, as well as to meet informed physician preferences for a particular medication formulation to treat a specific patient condition. There is a clear role for appropriate federal oversight and a role for the State Boards of Pharmacy to […] Read More »